Form 4 for PRVA Privia Health Group, Inc.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-08 · accession 0001759655-24-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-15 | 2024-03-08 | PRVA | Mountcastle David | EVP, CFO | A - Grant | $0.00 | +38.1K | 210.6K | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-03-08 | A | A | 38,058 | $0.00 | 210,596 | D | — | — | (F1) Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. |